JPS56142262A - Piperazine derivative - Google Patents

Piperazine derivative

Info

Publication number
JPS56142262A
JPS56142262A JP4644380A JP4644380A JPS56142262A JP S56142262 A JPS56142262 A JP S56142262A JP 4644380 A JP4644380 A JP 4644380A JP 4644380 A JP4644380 A JP 4644380A JP S56142262 A JPS56142262 A JP S56142262A
Authority
JP
Japan
Prior art keywords
formula
diseases
alkyl
piperazine derivative
ylideneoxido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4644380A
Other languages
English (en)
Other versions
JPS6330894B2 (ja
Inventor
Shingo Matsumura
Hiroshi Enomoto
Yoshiaki Aoyanagi
Haruo Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Priority to JP4644380A priority Critical patent/JPS56142262A/ja
Priority to GB8104474A priority patent/GB2073738B/en
Priority to FR8105521A priority patent/FR2479821A1/fr
Priority to US06/247,881 priority patent/US4435397A/en
Priority to IT8148162A priority patent/IT1209856B/it
Priority to DE3114239A priority patent/DE3114239C2/de
Priority to CH236781A priority patent/CH645887A5/de
Publication of JPS56142262A publication Critical patent/JPS56142262A/ja
Publication of JPS6330894B2 publication Critical patent/JPS6330894B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP4644380A 1980-04-08 1980-04-08 Piperazine derivative Granted JPS56142262A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP4644380A JPS56142262A (en) 1980-04-08 1980-04-08 Piperazine derivative
GB8104474A GB2073738B (en) 1980-04-08 1981-02-12 Piperazine derivatives
FR8105521A FR2479821A1 (fr) 1980-04-08 1981-03-19 Derives de n4-carbamoylpiperazinopropanol utiles pour leur activite de b-blocage d'adrenaline
US06/247,881 US4435397A (en) 1980-04-08 1981-03-26 Carbamylpiperazine compounds
IT8148162A IT1209856B (it) 1980-04-08 1981-03-31 Derivati di piperazina dotati di attivita' farmacologica
DE3114239A DE3114239C2 (de) 1980-04-08 1981-04-08 N↑4↑-Carbamoylpiperazinpropanolderivate, Verfahren zu ihrer Herstellung und pharmazeutisches Mittel
CH236781A CH645887A5 (de) 1980-04-08 1981-04-08 Piperazin-derivate.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4644380A JPS56142262A (en) 1980-04-08 1980-04-08 Piperazine derivative

Publications (2)

Publication Number Publication Date
JPS56142262A true JPS56142262A (en) 1981-11-06
JPS6330894B2 JPS6330894B2 (ja) 1988-06-21

Family

ID=12747304

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4644380A Granted JPS56142262A (en) 1980-04-08 1980-04-08 Piperazine derivative

Country Status (7)

Country Link
US (1) US4435397A (ja)
JP (1) JPS56142262A (ja)
CH (1) CH645887A5 (ja)
DE (1) DE3114239C2 (ja)
FR (1) FR2479821A1 (ja)
GB (1) GB2073738B (ja)
IT (1) IT1209856B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63290821A (ja) * 1987-05-25 1988-11-28 Otsuka Pharmaceut Co Ltd 抗不整脈剤
JPH07252153A (ja) * 1995-01-25 1995-10-03 Otsuka Pharmaceut Co Ltd 抗不整脈剤
WO1996019470A1 (fr) * 1994-12-19 1996-06-27 Idemitsu Kosan Co., Ltd. Procede de preparation d'un derive de pyrazole

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
US5443750A (en) * 1991-01-16 1995-08-22 The Procter & Gamble Company Detergent compositions with high activity cellulase and softening clays
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
US5614523A (en) * 1995-01-17 1997-03-25 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5741789A (en) 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5789402A (en) * 1995-01-17 1998-08-04 Eli Lilly Company Compounds having effects on serotonin-related systems
CA2530376A1 (en) * 2003-06-23 2005-01-06 Cv Therapeutics, Inc. Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
US20080076778A1 (en) * 2006-09-05 2008-03-27 Bipar Sciences, Inc. Methods for designing parp inhibitors and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5557578A (en) * 1978-10-23 1980-04-28 Nippon Shinyaku Co Ltd Carbamoylpiperazine derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2602792A (en) 1950-11-24 1952-07-08 American Cyanamid Co 1-carbocycliccarbamyl-4-heterocyclic-piperazines
NL299920A (ja) 1962-10-31
US3637852A (en) 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
GB1069343A (en) 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives
GB1095378A (ja) 1965-06-22
DE1643262C3 (de) 1967-12-13 1975-06-26 C.H. Boehringer Sohn, 6507 Ingelheim i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4045482A (en) 1968-11-12 1977-08-30 Yamanouchi Pharmaceutical Co. Ltd. 4-(3-Isopropylamino-2-hydroxypropoxy indene
DE1922003C3 (de) 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
DE2130393C3 (de) 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen
US3857873A (en) 1974-02-11 1974-12-31 Warner Lambert Co 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols
FR2267104A1 (en) * 1974-04-12 1975-11-07 Ferlux Labo Sa Hypotensive and antiarrhythmic piperazines - 1-(3-phenoxy-2-hydroxy propyl)-4-substd. piperazines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5557578A (en) * 1978-10-23 1980-04-28 Nippon Shinyaku Co Ltd Carbamoylpiperazine derivative

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63290821A (ja) * 1987-05-25 1988-11-28 Otsuka Pharmaceut Co Ltd 抗不整脈剤
WO1996019470A1 (fr) * 1994-12-19 1996-06-27 Idemitsu Kosan Co., Ltd. Procede de preparation d'un derive de pyrazole
JPH07252153A (ja) * 1995-01-25 1995-10-03 Otsuka Pharmaceut Co Ltd 抗不整脈剤

Also Published As

Publication number Publication date
FR2479821A1 (fr) 1981-10-09
FR2479821B1 (ja) 1983-04-22
US4435397A (en) 1984-03-06
IT1209856B (it) 1989-08-30
DE3114239A1 (de) 1982-02-18
IT8148162A0 (it) 1981-03-31
DE3114239C2 (de) 1986-04-03
CH645887A5 (de) 1984-10-31
GB2073738B (en) 1984-02-29
JPS6330894B2 (ja) 1988-06-21
GB2073738A (en) 1981-10-21

Similar Documents

Publication Publication Date Title
JPS56142262A (en) Piperazine derivative
JPS56135455A (en) Novel 2-cyanoacrylate and curable composition
DE3370478D1 (en) Isoquinolinesulfonamide derivatives and process for the preparation thereof
GB1177525A (en) New Heterocyclic Aminoketones of Therapeutic Interest
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
FI834702A (fi) Nya nitroalifatiska foereningar, deras framstaellningsfoerfarande och anvaendning.
RU93004472A (ru) Полициклические биоцидные соединения и композиция на их основе
KR910006310A (ko) 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체
JPS5515457A (en) Dithiocarbamic acid derivative
JPS5649385A (en) Novel s-triazolo- 1,5-a -pyrimidine derivative
JPS54128583A (en) Thiosemicarbazone derivative
JPS5632471A (en) Tetrazole derivative
JPS5524127A (en) 3,6-endomethylene-delta4-1,2,3,6-tetrahydrophtalimide derivative
JPS5770884A (en) Novel piperidine derivative and its preparation
JPS56142272A (en) Hydrazinopyridazine derivative
JPS54109974A (en) Novel imidazolecarboxylic ester derivative
JPS565469A (en) Novel amidine derivative and its preparation
JPS56150083A (en) Novel dibenzo b,e oxepin derivative
JPS525767A (en) Preparation of novel organic compounds
JPS5711975A (en) Aminophenyltetrazole derivative and salt thereof
JPS5795980A (en) 7-hydroxy pgi2 and its preparation
JPS55111448A (en) Novel butenophenone derivative
JPS5649360A (en) 2-oxoquinoline derivative
JPS56122372A (en) Prostaglandin i2 derivative
JPS56103178A (en) Pyrimidinoaminomethylenemalonic cyclic ester and its preparation